Effect of Hypercholesterolemia on Expression and Function of Vascular Soluble Guanylyl Cyclase

@article{Laber2002EffectOH,
  title={Effect of Hypercholesterolemia on Expression and Function of Vascular Soluble Guanylyl Cyclase},
  author={Ute Laber and Thorsten Kober and V Schmitz and Astrid Schrammel and Wilfried Meyer and Bernd Mayer and Martina Weber and Georg Kojda},
  journal={Circulation: Journal the of American Heart Association},
  year={2002},
  volume={105},
  pages={855-860}
}
  • Ute Laber, T. Kober, G. Kojda
  • Published 19 February 2002
  • Medicine, Biology
  • Circulation: Journal the of American Heart Association
Background—Vasorelaxation to endothelial NO is mediated by activation of soluble guanylyl cyclase (sGC) and impaired by hypercholesterolemia in animals and humans. We investigated whether hypercholesterolemia impacts expression and function of sGC. Methods and Results—White New Zealand rabbits (n=10 per group) received a standard diet for 16 weeks (SD16) (n=20) or 32 weeks (SD32) and a cholesterol diet (7.5 g/kg) for 16 weeks (CD16) (n=20) or 32 weeks (CD32), respectively. Another group… 

Figures from this paper

Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet‐fed rabbits
TLDR
The findings suggest that the sGC system was not normal in atherosclerotic coronary arteries, and the redox state of sGC and the distribution pattern are likely to change with the progression of atherosclerosis.
Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells
TLDR
Nebivolol therapy effectively prevents NO synthase III uncoupling and prevents activation of the neutrophil NAD(P)H oxidase and infiltration of inflammatory cells, which may explain partly the beneficial effects on endothelial function in patients with enhanced vascular oxidative stress.
Nitric Oxide and Cardiovascular Pharmacology nhibition of Vascular Oxidative tress in Hypercholesterolemia y Eccentric Isosorbide Mononitrate
TLDR
It is suggested that eccentric ISMN can completely inhibit the increase of vascular bioavailability of superoxide and partially prevent intimal lesion formation and endothelium-dependent vasorelaxation in hypercholesterolemia.
Inactivation of Soluble Guanylate Cyclase by Stoichiometric S-Nitrosation
TLDR
Protection by physiologically relevant concentrations of GSH suggests that S-nitrosation of sGC may contribute to vascular dysfunction in inflammatory disorders associated with nitrosative and oxidative stress and GSH depletion.
Chronological Change of Vascular Reactivity to cGMP Generators in the Balloon-Injured Rat Carotid Artery
TLDR
Balloon injury alters vascular responsiveness to cGMP generators, which seems to be associated with the form and/or expression of sGC.
...
1
2
3
4
...

References

SHOWING 1-10 OF 39 REFERENCES
Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats.
TLDR
Tissue-specific downregulation of components of the sGC/cGMP pathway is an early event in the pathogenesis of hypertension.
Effects of In Vivo Nitroglycerin Treatment on Activity and Expression of the Guanylyl Cyclase and cGMP-Dependent Protein Kinase and Their Downstream Target Vasodilator-Stimulated Phosphoprotein in Aorta
TLDR
It is concluded that increased expression of sGC in the setting of tolerance reflects a chronic inhibition rather than an induction of the sGC–cGK-I pathway and may be mediated at least in part by increased vascular superoxide.
Modulators of soluble guanylyl cyclase
  • D. Koesling
  • Biology, Medicine
    Naunyn-Schmiedeberg's Archives of Pharmacology
  • 1998
TLDR
Recently, a specific inhibitor of the NO-stimulated enzyme has been identified, offering the possibility to study the cGMP dependency of NO signalling, and an activator of sGC, YC-1, has be identified which stimulates the enzyme independently of NO, sensitizes the enzyme towards NO, and turns CO into an effective activators of s GC.
NO-independent regulatory site on soluble guanylate cyclase
TLDR
A pyrazolopyridine is presented that potently stimulates sGC through this site by a mechanism that is independent of NO, which results in antiplatelet activity, a strong decrease in blood pressure and an increase in survival in a low-NO rat model of hypertension, and may offer an approach for treating cardiovascular diseases.
Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia.
TLDR
The upregulation of soluble guanylate cyclase (sGC) may play an important role in the regulation of smooth muscle tone and pressure in the pulmonary circulation during chronic hypoxia.
In Vivo Effects of Pentaerythrityl‐Tetranitrate and Isosorbide‐5-Mononitrate on the Development of Atherosclerosis and Endothelial Dysfunction in Cholesterol‐Fed Rabbits
TLDR
It is concluded that long-term treatment with doses of PETN, which do not promote the development of in vitro vascular nitrate tolerance, may protect against atherosclerosis and endothelial dysfunction.
Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes.
TLDR
The results indicate that in cardiac muscle organic nitrate are bioactivated to NO and this results in a moderate increase in cGMP, which causes an improved CR by increasing cAMP and activating cAMP-dependent protein kinase; and a large increase in gMP, produced by high doses of NO donors, reduces CR because of the activation of CGMP-dependentprotein kinase.
...
1
2
3
4
...